日本生物医药产业发展现状与展望(1)
[摘要] 日本的生物技术领域正在快速变化中,政策改革和国外公司都向日本大型制药公司和企业集团提出了挑战,而他们掌握着日本的生物技术研究和发展资源。同时,股市对该领域的投资有所降温,日本的新兴生物技术的增长也面临着资金的挑战。本文主要从日本生物技术医药产业的政策促进、产业现状、资本市场、企业战略等几个方面进行了分析,展望了日本生物医药产业的前景。
[关键词] 日本;生物医药产业;发展现状
[中图分类号]F752 [文献标识码]C [文章编号]1673-7210(2010)01(a)-141-03
The status quo and prospect on the development of Japan's biomedical industry
ZHANG Zhiran1, DIAO Tianxi2, GAO Yunhua2
(1.Department of Pharmacy, PLA 210 Hospital, Dalian 116021, China; 2.Academy of Military Medical Sciences, Beijing 100850, China)
[Abstract] The field of biotechnology is changing rapidly in Japan, the challenges that faced to some large Japanese pharmaceutical companies and enterprises are the policy reforms and foreign competitors, which are in control of Japan's biotechnological research and developmental resource. At the same time, with the public equity investment in such field is dying down, the growth of Japan's emerging biotechnology are also encounter challenges such as funds. In this paper, the promotion of policy, the status quo of industry, the capital market and the main M&A League of enterprises and industries have been analyzed, meanwhile, the prospects of biotechnology in Japan have been looking ahead. ......
您现在查看是摘要页，全文长 4824 字符。
[关键词] 日本;生物医药产业;发展现状
[中图分类号]F752 [文献标识码]C [文章编号]1673-7210(2010)01(a)-141-03
The status quo and prospect on the development of Japan's biomedical industry
ZHANG Zhiran1, DIAO Tianxi2, GAO Yunhua2
(1.Department of Pharmacy, PLA 210 Hospital, Dalian 116021, China; 2.Academy of Military Medical Sciences, Beijing 100850, China)
[Abstract] The field of biotechnology is changing rapidly in Japan, the challenges that faced to some large Japanese pharmaceutical companies and enterprises are the policy reforms and foreign competitors, which are in control of Japan's biotechnological research and developmental resource. At the same time, with the public equity investment in such field is dying down, the growth of Japan's emerging biotechnology are also encounter challenges such as funds. In this paper, the promotion of policy, the status quo of industry, the capital market and the main M&A League of enterprises and industries have been analyzed, meanwhile, the prospects of biotechnology in Japan have been looking ahead. ......
您现在查看是摘要页，全文长 4824 字符。